Merck

4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic
24/7 Wall St
Thu, 11/13/14 - 09:34 am
hepatitis C
AbbVie
Achillion
Gilead Sciences
Merck
U.S. gene study raises hope for Merck cholesterol drug Zetia
Yahoo/Reuters
Thu, 11/13/14 - 08:11 am
Merck
Zetia
1 Biotech Beast Worth Tracking
Yahoo/Benzinga
Wed, 11/12/14 - 04:37 pm
Incyte
Merck
Novartis
Eli Lilly
Pfizer
Are Expensive Biotech Drugs Bad For Business?
Seeking Alpha
Tue, 11/11/14 - 10:53 am
drug pricing
biotech
AbbVie
AstraZeneca
Bristol-Myers Squibb
Dendreon
Gilead Sciences
GSK
Merck
Novartis
Teva Pharmaceutical
Vertex Pharmaceuticals
Does a Positive Result for the Vytorin Trial Really Help Merck?
WSJ Pharmalot
Tue, 11/11/14 - 10:33 am
Merck
Vytorin
Zetia
clinical trial data
Merck expects no writedowns for Zetia, Vytorin cholesterol drugs
Yahoo/Reuters
Mon, 11/10/14 - 03:53 pm
Merck
Zetia
Vytorin
Merck, Dendreon miss out on health-care rally
Marketwatch
Mon, 11/10/14 - 03:51 pm
Merck
Dendreon
Merck’s Four-Week Hepatitis C Regimen Fails to Top Gilead
Bloomberg
Mon, 11/10/14 - 07:57 am
hepatitis C
Merck
Gilead Sciences
grazoprevir
elbasvir
Sovaldi
Biotech stocks to watch ahead of liver disease conference
CNBC
Fri, 11/7/14 - 03:54 pm
liver disease
Gilead Sciences
Intercept Pharma
Genfit
Merck
Achillion
AbbVie
NASH
hepatitis B
hepatitis C
Merck says animal food additive Zilmax seen safe in review
Yahoo/Reuters
Wed, 11/5/14 - 01:37 pm
Merck
animal health
Zilmax
Pharma's top 10 M&A deals of 2014's first half
Fierce Pharma
Mon, 11/3/14 - 08:57 am
M&A
Actavis
Forest Labs
GSK
Novartis
Bayer
Merck
Mallinckrodt
Questcor Pharmaceuticals
Eli Lilly
Idenix
Nestle
Galderma
Sun Pharma
Ranbaxy
Aptalis
Abbott Labs
CFR
How Merck Found Its Way Into Millions Of Medicine Cabinets
Investopedia.com
Mon, 11/3/14 - 08:06 am
Merck
If It’s Bad For Merck, It’s Good For Gilead
Barron's
Mon, 10/27/14 - 03:25 pm
Merck
Gilead Sciences
hepatitis C
Sovaldi
JNJ
Olysio
Merck grabs another 'breakthrough' in PD-1 lung cancer race with Bristol-Myers
Fierce Biotech
Mon, 10/27/14 - 09:10 am
Merck
Bristol-Myers Squibb
anti-PD-1 immunotherapy
lung cancer
Keytruda
Expirations, drop in hep C sales hit Merck sales
CNBC
Mon, 10/27/14 - 07:17 am
Merck
earnings
FDA Accepts for Review a Biologics License Application for Merck and Sanofi’s Investigational Pediatric Hexavalent Vaccine
Yahoo
Mon, 10/20/14 - 10:24 am
FDA
Sanofi Pasteur
pediatric hexavalent vaccine
Merck
vaccines
diphtheria
tetanus
pertussis
Hib
hepatitis B
Roche, Merck extend immunotherapy fight to breast cancer
Yahoo/Reuters
Fri, 10/17/14 - 10:08 am
Roche
Merck
breast cancer
MPDL3280A
Keytruda
Merck unit to pay $31 mln to settle fraud claims by U.S. states
Yahoo/Reuters
Wed, 10/15/14 - 04:44 pm
Merck
Medicaid
Medicaid fraud
whistleblower lawsuits
Organon
Companies That Could Develop An Enterovirus Treatment
Yahoo/Benzinga
Mon, 10/13/14 - 09:16 am
enterovirus
AbbVie
Alnylam
Gilead Sciences
Bristol-Myers Squibb
Merck
Biocryst
Chimerix
Tekmira
Sarepta Therapeutics
Merck Must Face Sex Discrimination Lawsuit Claiming a “Boys’ Club”
WSJ Pharmalot
Thu, 10/9/14 - 06:19 pm
Merck
gender discrimination

Pages